Market Tracker

05/28 2:10pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

10.16
BATS BZX Real-Time Price
As of 2:06pm ET
 -0.235 / -2.26%
Today’s Change
8.84
Today|||52-Week Range
18.48
-28.16%
Year-to-Date

Today’s Trading

Previous close10.40
Today’s open10.34
Day’s range10.07 - 10.37
Volume370,891
Average volume (3 months)1,804,114
Market cap$1.1B
Dividend yield--
Data as of 1:54pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+22.85%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book12.98

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc-0.15-0.80%
NXTMNxStage Medical Inc+0.19+1.16%
DBVTDBV Technologies SA-0.11-0.46%
BRLIBio-Reference Labora...+0.10+0.30%
Data as of 2:09pm ET, 05/28/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
James F. Oliviero
Corporate headquarters
New York, New York

Forecasts